Výsledky vyhledávání - "Y. Armendariz"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PMU68 THE ROLE OF OUTCOMES-BASED MODELS FOR THE REIMBURSEMENT OF MEDICINES IN THE UK NATIONAL HEALTH SERVICE

Autor: A. Halliday, Y. Armendariz, J.J. Walsh, C. Evans

Publikováno v: Value in Health. 22:S720

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70dc34836e36e1b83a42864c35c14abe
https://doi.org/10.1016/j.jval.2019.09.1687

Zobrazit plný text záznamu

Determination of ganciclovir in human plasma by ultra performance liquid chromatography–UV detection

Autor: Ariadna Padullés, Helena Colom, Gema Cerezo, A Caldés, L. Pou, Nuria Lloberas, Joan Torras, Josep M. Grinyó, Y. Armendariz

Publikováno v: Clinical Biochemistry. 45:309-314

Objectives Implement a sensitive UHPLC method for the assay of ganciclovir in human plasma. Design and methods We developed and validated a chromatographic method coupled to ultraviolet detection for quantification of ganciclovir, with a short run ti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d074ccddf3d5f62160e369945b8356c
https://doi.org/10.1016/j.clinbiochem.2011.12.014

Zobrazit plný text záznamu

PSS7 - QUALITY OF LIFE IMPROVEMENTS IN PSORIASIS WITH SECUKINUMAB IN A DIFFICULT TO TREAT POPULATION OF ANTI-TNF ALPHA FAILURE PATIENTS FROM THE UK AND REPUBLIC OF IRELAND

Autor: J. Barker, A Halliday, Y. Armendariz, D. Burden, Richard B. Warren, Cem Griffiths, R. Williams, Andrew Yule Finlay

Publikováno v: Value in Health. 21:S423

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::269f6f18742f638a6a7692c08fa548a5
https://doi.org/10.1016/j.jval.2018.09.2507

Zobrazit plný text záznamu

Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics

Autor: S. Gil-Vernet, Jordi Niubó, L. Pou, Nicolás Manito, Y. Armendariz, Ana Caldés, Gabriel Rufi, Josep M. Grinyó, Joan Torras, Laura Lladó, Helena Colom

Publikováno v: Transplant Infectious Disease. 12:204-212

Oral (p.o.) or intravenous (IV) ganciclovir (GCV) has been the first-line agent for prevention and treatment of cytomegalovirus (CMV) infection and disease in solid organ transplantation (SOT). The introduction of p.o. valganciclovir, with higher bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4dc33b93894af65e09254efebf881594
https://doi.org/10.1111/j.1399-3062.2009.00481.x

Zobrazit plný text záznamu

Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus

Autor: Nuria Lloberas, Y. Armendariz, L. Pou, María J. Garrido, Concepción Peraire, Ana Caldés, Josep M. Grinyó, Helena Colom, Iñaki F. Trocóniz, S. Gil-Vernet

Publikováno v: Dadun. Depósito Académico Digital de la Universidad de Navarra
instname

A population pharmacokinetics analysis was performed after intravenous ganciclovir and oral valganciclovir in solid organ transplant patients with cytomegalovirus. Patients received ganciclovir at 5 mg/kg of body weight (5 days) and then 900 mg of va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31fbf8474fc932fc6e25bfbed48a855d
https://doi.org/10.1128/aac.00085-09

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání